ESP / ENG

About the fund

The Global Fund is using many ways to rally donors ahead of the Seventh Replenishment Conference

Source: aidspan.org The Global Fund’s Seventh Replenishment comes at a time the world is facing unprecedented financial pressures due to multiple reasons. The Global Fund is seeking $18 billion to continue its fight against AIDS, tuberculosis (TB), malaria, and to...
Read More

A successful hybrid 47th Global Fund Board Meeting; and its main decision points

Source: aidspan.org In spite of confusion regarding the various scenarios for the Catalytic Investments and demands for more discussion on the Strategy implementation Hot off the press, this special edition of the Global Fund Observer brings you all the latest from...
Read More

Global Fund Signs Letter of Intent with Pfizer for Oral COVID-19 Treatment

Source: theglobalfund.org Geneva - The Global Fund has signed a letter of intent with Pfizer for the procurement of up to 6 million treatment courses of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™, in 2022-2023. Thanks to...
Read More

Calls for increased prioritization and visibility of the Community, Rights and Gender portfolio in Global Fund core operations

Source: aidspan.org Among the several background papers for information provided to the 47th Board meeting held on 10-12 May 2022 was the annual update on Community, Rights and Gender. While members appreciated the progress that had been made, they also felt that the...
Read More